Article info
Research ethics
Can artificial parthenogenesis sidestep ethical pitfalls in human therapeutic cloning? An historical perspective
- Correspondence to: Dr H Fangerau Institute for the History of Medicine, Heinrich-Heine University Düsseldorf, Universitaetsstrasse 1, 40225 Düsseldorf, Germany; heiner.Fangerau{at}uni-duesseldorf.de
Citation
Can artificial parthenogenesis sidestep ethical pitfalls in human therapeutic cloning? An historical perspective
Publication history
- Received July 29, 2004
- Accepted March 16, 2005
- Revised December 26, 2004
- First published November 30, 2005.
Online issue publication
November 30, 2005
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by the Journal of Medical Ethics
Other content recommended for you
- Human embryonic stem cell research debates: a Confucian argument
- The significance of induced pluripotent stem cells for basic research and clinical therapy
- Regenerative medicine: stem cells and the science of monstrosity
- What happened to the stem cells?
- Is a consensus possible on stem cell research? Moral and political obstacles
- Adam’s fibroblast? The (pluri)potential of iPCs
- Time to reconsider stem cell ethics—the importance of induced pluripotent cells
- Artificial gametes: new paths to parenthood?
- Stem cells as a resource for regenerative neurology
- Stem cells, embryos, and the environment: a context for both science and ethics